Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease

Veterinary Immunology and Immunopathology

Volumn 100, Issue 3-4, 2004, Pages 165-177

  Baaten, B J G ^a,b   Butter, C ^a   Davison, T F ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

Chicken; Herpesvirus; Immunity; Marek's disease; Vaccine

Indexed keywords

CYTOKINE; MAREK DISEASE VACCINE;

ALPHA VIRUS; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BIRD DISEASE; CANCER; CELLULAR IMMUNITY; CHICKEN; CONFERENCE PAPER; CYTOLYSIS; DOWN REGULATION; GENETIC RESISTANCE; GENETIC TRANSFORMATION; HOST PATHOGEN INTERACTION; HOST SUSCEPTIBILITY; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIFE CYCLE; LYMPHOID CELL; NEOPLASM; NONHUMAN; ONCOGENE; PARALYSIS; T LYMPHOCYTE; VACCINATION; VIRUS ATTENUATION; VIRUS INFECTION;

ANIMALS; ANTIBODY FORMATION; CHICKENS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HERPESVIRUS 2, GALLID; IMMUNITY, CELLULAR; MAREK DISEASE; MAREK DISEASE VACCINES; VACCINATION;

GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE;

EID: 2942741144     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2004.04.009     Document Type: Conference Paper

References (148)

1. Adldinger H., Calnek B. Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens. J. National Cancer Inst. 50:1973;1287-1298
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:2002;1323-1326
3. Baaten B.J.G., Davison F., Burgess S.C. DELFIA to detect the humoral response against a tumour antigen. Immunology. 98:1999;126
4. Bacon, L.D., Hunt, H.D., Cheng, H.H., 2001. Pathogenesis of Marek's disease virus infection. In: Hirai, K. (Ed.), Current Topics in Microbiology and Immunology. Springer, Berlin, pp. 121-141.
5. Barrow A.D., Burgess S.C., Baigent S., Howes K., Nair V.K. Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus. J. Gen. Virol. 84:2003;2635-2645
6. Beasley J.N., Patterson L.T., McWade D.H. Transmission of Marek's disease by poultry house dust and chicken dander. Am. J. Vet. Res. 31:1970;339-344
7. Biggs P.M. A discussion on the classification of the avian leucosis complex and fowl paralysis. Brit. Vet. J. 117:1961;326-334
8. Biron C.A. Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:1998;383-390
9. Bourne, F.J., 1996. Research priorities for the future. In: Davison, T.F., Morris, T.R., Payne, L.N. (Eds.), Poultry Immunology. Carfax Publishing Company, Abingdon, pp. 419-432.
10. Briles W.E., Stone H.A., Cole R.K. Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines. Science. 195:1977;193-195
11. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R.C., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:2001;934-937
12. Brunovskis, P., 1992. In: Proceedings of the XIX World's Poultry Congress, Amsterdam, pp. 118-121.
13. Buckmaster A.E., Scott S.D., Sanderson M.J., Boursnell M.E.G., Ross N.L.J., Binns M.M. Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys - implications for herpesvirus classification. J. Gen. Virol. 69:1988;2033-2042
14. Bucy R.P., Chen C.H., Cooper M.D. Development of cytoplasmic CD3+ T cell receptor-negative cells in the peripheral lymphoid tissues of chickens. Eur. J. Immunol. 20:1990;1345-1350
15. Bucy R.P., Coltey M., Chen C.L.H., Char D., Ledouarin N.M., Cooper M.D. Cytoplasmic CD3+ surface CD8+ lymphocytes develop as a thymus-independent lineage in chick-quail chimeras. Eur. J. Immunol. 19:1989;1449-1455
16. Bumstead N. Genomic mapping of resistance to Marek's disease. Avian Pathol. 27:1998;S78-S81
17. Burgoyne G.H., Witter R.L. Effect of passively transferred immunoglobulins on Marek's disease. Avian Dis. 17:1973;824-837
18. Buscaglia C., Calnek B.W., Schat K.A. Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J. Gen. Virol. 69:1988;1067-1077
19. Calnek B.W. Influence of age on exposure on the pathogenesis of Marek's disease. J. National Cancer Inst. 51:1973;929-939
20. Calnek B.W. Effects of passive antibody on early pathogenesis of Marek's disease. Infect. Immun. 6:1972;193-205
21. Calnek, B.W., 1985. Genetic resistance. In: Payne, L.N. (Ed.), Marek's Disease. Martinus Nijhoff Publishing, Boston, pp. 293-328.
22. Calnek, B.W., 2001. Pathogenesis of Marek's disease virus infection. In: Hirai, K. (Ed.), Current Topics in Microbiology and Immunology. Springer, Berlin, pp. 25-55.
23. Calnek B.W., Adldinger H.K., Kahn D.E. Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis. 14:1970;219-233
24. Calnek B.W., Harris R.W., Buscaglia C., Schat K.A., Lucio B. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates. Avian Dis. 42:1998;124-132
25. Calnek, B.W., Schat, A.K., Heller, E.D., Buscaglia, C., 1984a. In vitro infection of T-lymphoblasts with Marek's disease virus. In: An International Symposium on Marek's Disease, Cornell University, Ithaca, pp. 173-187.
26. Calnek B.W., Schat A.K., Peckham M.C., Fabricant J. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease. Avian Dis. 27:1983;844-849
27. Calnek B.W., Schat A.K., Ross L.N.J., Chen C.H. Further characterization of Marek's disease virus-infected lymphocytes. II. In vitro infection. Int. J. Cancer. 33:1984;399-406
28. Calnek B.W., Schat K.A., Shek W.R., Chen C.L.H. In vitro infection of lymphocytes with Marek's disease virus. J. National Cancer Inst. 69:1982;709-713
29. Chatterjee M., Osborne J., Bestetti G., Chang Y., Moore P.S. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science. 298:2002;1432-1435
30. Chubb R.C., Churchill A.E. Precipitating antibodies associated with Marek's disease. Vet. Rec. 83:1968;4-7
31. Chubb R.C., Churchill A.E. Effect of maternal antibody on Marek's disease. Vet. Rec. 85:1969;303-305
32. Churchill A.E., Biggs P.M. Agent of Marek's disease in tissue culture. Nature. 215:1967;528-530
33. Churchill A.E., Chubb R.C. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J. Gen. Virol. 4:1969;557-564
34. Cole R.K. Studies on genetic resistance to Marek's disease. Avian Dis. 12:1968;9-28
35. Dandapat S., Pradhan H., Mohanty G. Anti-idiotype antibodies to Marek's disease-associated tumour surface antigens in protection against Marek's disease. Vet. Immunol. Pathol. 40:1994;353-366
36. Daniels K.A., Devora G., Lai W.C., O'Donnell C.L., Bennett M., Welsh R.M. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194:2001;29-44
37. Deng H.Y., Chu J.T., Rettig M.B., Martinez-Maza O., Sun R. Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood. 100:2002;1919-1921
38. Djeraba A., Bernardet N., Dambrine G., Quere P. Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition. Virology. 277:2000;58-65
39. Djeraba A., Musseet E., Bernardet N., Le Vern Y., Quere P. Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek's disease. Vet. Immunol. Immunopathol. 85:2002;63-75
40. Eidson C.S., Page R.K., Kleven S.H. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus. Avian Dis. 22:1978;583-597
41. Emara M.G., Abdellatif M.A., Pollock D.L., Sadjadi M., Cloud S.S., Pope C.R., Rosenberger J.K., Kim H. Genetic variation in susceptibility to Marek's disease in a commercial broiler population. Avian Dis. 45:2001;400-409
42. Epstein M.A. Historical background. Phil. Trans. R. Soc. Lond., Ser. B: Biol. Sci. 356:2001;413-420
43. Fredericksen T.L., Longenecker B.M., Pazderka F., Gilmour D.G., Ruth R.F. A T cell antigen system of chickens: Ly-4 and Marek's disease. Immunogenetics. 5:1977;535-552
44. Gandon S., Mackinnon M.J., Nee S., Read A.F. Imperfect vaccines and the evolution of pathogen virulence. Nature. 414:2001;751-756
45. Geerligs H.J., Weststrate M.W., Pertile T.L., Rodenberg J., Kumar M., Chu S. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV. Acta Virol. 43:1999;198-200
46. Gildow E.M., Williams J.K., Lampman C.E. The transmission of and resistance to fowl paralysis (lymphomatosis). Univ. Idaho Agric. Exp. Stat. Bull. 235:1940;1-22
47. Gilmour D.G., Brand A., Donelly N., Stone H.A. BU-1 and Th-1, two loci determining surface antigens of B lymphocytes or T lymphocytes in the chickens. Immunogenetics. 3:1976;549-563
48. Gobel T.W.F., Chen C.H., Cooper M.D. Avian natural killer cells. Curr. Topics Microbiol. Immunol. 212:1996;107-111
49. Gobel T.W.F., Chen C.L.H., Shrimpf J., Grossi C.E., Bernot A., Bucy R.P., Auffray C., Cooper M.D. Characterization of avian natural killer cells and their intracellular CD3 protein complex. Eur. J. Immunol. 24:1994;1685-1691
50. Gracie J.A., Robertson S.E., McInnes I.B. Interleukin-18. J. Leukoc. Biol. 73:2003;213-224
51. Gupta M.K., Chauhan H.V.S., Jha G.J., Singh K.K. The role of the reticuloendothelial system in the immunopathology of Marek's disease. Vet. Microbiol. 20:1989;223-234
52. Haffer K., Sevoian M. In vitro studies on the role of the macrophages of resistant and susceptible chickens with Marek's disease. Poult. Sci. 58:1979;295-297
53. Haffer K., Sevoian M., Wilder M. The role of the macrophage in Marek's disease: in vitro and in vivo studies. Int. J. Cancer. 23:1979;648-656
54. Hansen M.P., Van Zandt J.N., Law G.R.J. Differences in susceptibility to Marek's disease in chickens carrying two different B locus blood group alleles. Poult. Sci. 46:1967;1268
55. Heller E.D., Schat K.A. Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathol. 16:1987;51-60
56. Higgens D.A., Calnek B.W. Some effects of silica treatment on Marek's disease. Infect. Immun. 13:1976;1054-1060
57. Hofmann A., Plachy J., Hunt L., Kaufman J., Hala K. v-src oncogene-specific carboxy-terminal peptide is immunoprotective against Rous sarcoma growth in chickens with MHC class I allele B-F12. Vaccine. 21:2003;4694-4699
58. Hong C.C., Sevoian M. Interferon production and host resistance to type II avian (Marek's) leukosis virus (JM strain). Appl. Microbiol. 22:1971;818-820
59. Hunt H.D., Lupiani B., Miller M.M., Gimeno I., Lee L.F., Parcells M.S. Marek's disease virus down-regulates surface expression of MHC (B complex) class 1 (BF) glycoproteins during active but not latent infection of chicken cells. Virology. 282:2001;198-205
60. Hussain I., Qureshi M.A. Nitric oxide synthase activity and mRNA expression in chicken macrophages. Poult. Sci. 76:1997;1524-1530
61. Ikuta K., Ueda S., Kato S., Hirai K. Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization. J. Virol. 49:1984;1014-1017
62. Islam A.F.M.F., Walkden-Brown S.W., Burgess S.K., Groves P.J. Marek's disease in broiler chickens: effect of route of infection and herpesvirus of turkey-vaccination status on detection of virus from blood or spleen by polymerase chain reaction, and on weights of birds, bursa and spleen. Avian Pathol. 30:2001;621-628
63. Jarosinski K.W., O'Connell P.H., Schat K.A. Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4. Virus Genes. 26:2003;255-269
64. Jurajda V., Klimes B. Presence and survival of Marek's disease agent in dust. Avian Dis. 14:1970;188-190
65. Kaaden O.R. Marek's disease virus-induced antigens in relation to immunity. Avian Pathol. 6:1977;219-225
66. Kaiser P., Underwood G., Davison F. Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J. Virol. 77:2003;762-768
67. Kaufman J., Venugopal K. The importance of MHC for Rous sarcoma virus and Marek's disease virus - some Payne-ful considerations. Avian Pathol. 27:1998;S82-S87
68. Kaufman J., Volk H., Wallny H.J. A minimal essential MHC and an unrecognized MHC: Two extremes in selection for polymorphism. Immunol. Rev. 143:1995;63-88
69. Kenzy S.G., Cho B.R. Transmission of classical Marek's disease by affected and carrier birds. Avian Dis. 13:1969;211-214
70. Kodama H., Mikami T., Inoue M., Izawa H. Inhibitory effects of macrophages against Marek's disease virus plaque formation in chicken kidney cell cultures. J. National Cancer Inst. 63:1979;1267-1271
71. Lee L.F. Macrophage restriction of Marek's disease virus replication and lymphoma cell proliferation. J. Immunol. 123:1979;1088-1091
72. Lee L.F., Powell P.C., Rennie M., Ross L.N.J., Payne L.N. Nature of genetic resistance to Marek's disease in chickens. J. National Cancer Inst. 66:1981;789-796
73. Lee L.F., Sharma J.M., Nazerian K., Witter R.L. Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkeys. Infect. Immun. 21:1978;474-479
74. Lee L.F., Sharma J.M., Nazerian K., Witter R.L. Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus. J. Immunol. 120:1978;1554-1559
75. Lee S.H., Girard S., Macina D., Busa M., Zafer A., Belouchi A., Gros P., Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:2001;42-45
76. Li, J., Zhao, X., Yang, J., Liu, C., Li, X., Tian, Z., Xu, Y., 1996. Primary studies on immunoprotectivity of Marek's disease virus DNA vaccine. In: Silva, R.F., Cheng, H.H., Coussens, P.M., Lee, L.F., Velicer, L.F. (Eds.), Current Research on Marek's Disease. American Association of Avian Pathologists, Pennsylvania, pp. 367-371.
77. Li S., Aggrey S.E., Zadworny D., Fairfull W., Kuhnlein U. Evidence for a genetic variation in the mitochondrial genome affecting traits in White Leghorn chickens. J. Hered. 89:1998;222-226
78. Li S., Zadworny D., Aggrey S.E., Kuhnlein U. Mitochondrial PEPCK: a highly polymorphic gene with alleles co-selected with Marek's disease resistance in chickens. Anim. Genet. 29:1998;395-397
79. Liu H.C., Kung H.J., Fulton J.E., Morgan R.W., Cheng H.H. Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9203-9208
80. Liu J.L., Lin S.F., Brunovskis P., Li D., Davidson I., Lee L.F., Kung H.J. MEQ and v-IL8: Cellular genes in disguise. Acta Virol. 43:1999;94-101
81. Longenecker B.M., Mosmann T.R. Nomenclature for chicken MHC (B) antigens defined by monoclonal antibodies. Immunogenetics. 13:1981;25-28
82. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene - 2 upstream regions mediate induction by interferon-gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9730-9734
83. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350
84. Marek J. Multiple Nerventzundung (polyneuritis) bei Huhnern. Deutsche Tierartzzeitung Wschr. 15:1907;417-421
85. Markowski-Grimsrud C.J., Schat A.K. Cytotoxic T lymphocyte responses to Marek's disease herpesvirus-encoded glycoproteins. Vet. Immunol. Immunopathol. 90:2002;133-144
86. Medveczky, P.G., Friedman, H., Bendinelli, M., 1998. Herpesviruses and Immunity. Plenum Press, New York and London.
87. Nazerian K., Lee L., Yanagida N., Ogawa R. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J. Virol. 66:1992;1409-1413
88. Nazerian K., Witter R., Lee L., Yanagida N. Protection and synergism by recombinant Fowl Pox vaccines expressing genes from Marek's disease virus. Avian Dis. 40:1996;368-376
89. Netea M.G., Kullberg B.J., Verschueren I., Van der Meer J.W.M. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1 beta. Eur. J. Immunol. 30:2000;3057-3060
90. Okamura H., Sakaguchi M., Yokogawa K., Tokunaga E., Abe S., Tokiyoshi S., Mizuno K. Lack of contact transmission of recombinant Marek's disease virus type 1 expressing the fusion protein of Newcastle disease virus. Vaccine. 20:2001;483-489
91. Okazaki W., Purchase H.G., Burmester B.R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14:1970;413-429
92. Omar A.R., Schat K.A. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology. 222:1996;87-99
93. Omar A.R., Schat K.A. Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology. 90:1997;579-585
94. Palladino M.A., Gilmour D.G., Scafuri A.R., Stone H.A., Thorbecke G.J. Immune response differences between two inbred chickens lines identical at the major histocompatibility complex. Immunogenetics. 5:1977;253-259
95. Pappenheimer A.M., Dunn L.C., Cone V. A study of fowl paralysis (neuro-lymphomatosis gallinarum). Storrs Agric. Exp. Stat. Bull. 143:1926;186-190
96. Parcells M.S., Lin S.F., Dienglewicz R.L., Majerciak V., Robinson D.R., Chen H.C., Wu Z.N., Dubyak G.R., Brunovskis P., Hunt H.D., Lee L.F., Kung H.J. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75:2001;5159-5173
97. Payne L.N., Frazier J.A., Powell P.C. Pathogenesis of Marek's disease. Int. Rev. Exp. Pathol. 16:1976;59-154
98. Powell P.C. Marek's disease: a worldwide problem. World's Poult. Sci. 42:1986;205-218
99. Purchase H.G., Okazaki W. Effect of vaccination with herpesvirus of turkeys (HVT) on horizontal spread of Marek's disease herpesvirus. Avian Dis. 15:1971;391-397
100. Qureshi M.A., Heggen C.L., Hussain I. Avian macrophage: effector functions in health and disease. Dev. Comp. Immunol. 24:2000;103-119
101. Reiss C.S., Komatsu T. Does nitric oxide play a critical role in viral infections. J. Virol. 72:1998;4547-4551
102. Rispens B.H., Vloten Van H.J., Mastenbroek H., Maas H.J.L., Schat K.A. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI988) and its use in laboratory vaccination trials. Avian Dis. 16:1972;108-125
103. Rivas C., Djeraba A., Musset E., van Rooijen N., Baaten B., Quere P. Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease. Avian Pathol. 32:2003;139-149
104. Ross L.J. Antiviral T cell-mediated immunity in Marek's disease. Nature. 268:1977;644-646
105. Ross L.J.N. Recombinant vaccines against Marek's disease. Avian Pathol. 27:1998;S65-S73
106. Schat K.A., Calnek B.W. In vitro inactivation of cell-free Marek's disease herpesvirus by immune peripheral blood lymphocytes. Avian Dis. 22:1978;693-697
107. Schat K.A., Calnek B.W., Fabricant J. Influence of the bursa of Fabricius on the pathogenesis of Marek's disease. Infect. Immun. 31:1980;199-207
108. Schat, K.A., Markowski-Grimsrud, C.J., 2001. Immune responses to Marek's disease virus infection. In: Hirai, K. (Ed.), Current Topics in Microbiology and Immunology. Springer, Berlin, pp. 91-120.
109. Schat K.A., Pratt W.D., Morgan R., Weinstock D., Calnek B.W. Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 36:1992;432-439
110. Schat K.A., Shek W.R., Calnek B.W., Abplanalp H. Syngeneic and allogeneic cell-mediated cytotoxicity against Marek's disease lymphoblastoid tumor cell lines. Int. J. Cancer. 29:1982;187-194
111. Schat K.A., Xing Z. Specific and nonspecific immune responses to Marek's disease virus. Dev. Comp. Immunol. 24:2000;201-221
112. Schmittle S.C., Eidson C.S. Studies on acute Marek's disease. IV. Relative susceptibility of different lines and crosses of chickens to GA isolate. Avian Dis. 12:1968;571-576
113. Screpanti I., Musiani P., Bellavia D., Cappelletti M., Aiello F.B., Maroder M., Frati L., Modesti A., Gulino A., Poli V. Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J. Exp. Med. 184:1996;1561-1566
114. Secombes, C.J., Kaiser, P., 2003. The phylogeny of cytokines. In: Thomson, A.W., Lotze, M.T. (Eds.), The Cytokine Handbook. Elsevier, London, pp. 57-84.
115. Settnes O.P. A common naturally herpesvirus-induced lymphoma of the chicken - aspects of pathology, virology, immunology and genetics in relation to contemporary biomedical-research: a comprehensive review. Nordisk Veterinaer Medicin. 34:1982;S11-S132
116. Sevoian M., Chamberlain D.M., Larose R.N. Avian lymphomatosis. V. Air-borne transmission. Avian Dis. 7:1963;102-105
117. Sharma J., Witter R., Purchase H. Absence of age-resistance in neonatally thymectomised chickens as evidence for cell-mediated immune surveillance in Marek's disease. Nature. 253:1975;477-479
118. Sharma J.M. Lack of threshold of genetic resistance to Marek's disease and the incidence of humoral antibody. Avian Pathol. 2:1973;75-90
119. Sharma J.M. In vitro suppression of T-cell mitogenic response and tumor cell proliferation by spleen macrophages from normal chickens. Infect. Immun. 28:1980;914-922
120. Sharma J.M. Natural killer cell activity in chickens exposed to Marek's disease virus: inhibition of activity in susceptible chickens and enhancement in resistant and vaccinated chickens. Avian Dis. 25:1981;882-893
121. Shek W., Calnek B., Schat K., Chen C. Characterization of Marek's disease virus-infected lymphocytes: discrimination between cytolytically and latently infected cells. J. National Cancer Inst. 70:1983;485-491
122. Stout R.D. Macrophage activation by T cells: cognate and non-cognate signals. Curr. Opin. Immunol. 5:1993;398-403
123. Sunyer T., Rothe L., Jiang X.S., Osdoby P., CollinOsdoby P. Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells. J. Cell. Biochem. 60:1996;469-483
124. Thompson G., Naqi S. Cytotoxic activity of cells recovered from the respiratory tracts of chickens inoculated with infectious bronchitis virus. Avian Dis. 41:1997;690-694
125. Tischer B.K., Schumacher D., Beer M., Beyer J., Teifke J.P., Osterrieder K., Wink K., Zelnik V., Fehler F., Osterrieder N. A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. J. Gen. Virol. 83:2002;2367-2376
126. Tosato G., Tanner J., Jones K.D., Revel M., Pike S.E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol. 64:1990;3033-3041
127. Toth T.E. Nonspecific cellular defense of the avian respiratory system: a review. Dev. Comp. Immunol. 24:2000;121-139
128. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., Kutish G.F. The genome of a very virulent Marek's disease virus. J. Virol. 74:2000;7980-7988
129. Uni Z., Pratt W.D., Miller M.M., Oconnell P.H., Schat K.A. Syngeneic lysis of reticuloendotheliosis virus transformed cell lines transfected with Marek's disease virus genes by virus specific cytotoxic T cells. Vet. Immunol. Immunopathol. 44:1994;57-69
130. Van Regenmortel, M.H.V., Fauqet, C.M., Bishop, D.H.L., Carstens, E., Estes, M.K., Lemon, S., Maniloff, J., Mayo, M.A., McGeoch, D., Pringle, C.R., Wickner, R.B., 1999. In: Proceedings of the Seventh Report of the International Committee on Taxonomy of Viruses. Virus Taxonomy. Academic Press, New York.
131. Van Zaane D., Brinkhof J., Westenbrink F., Gielkens A. Molecular biological characterization of Marek's disease Virus. I. Identification of virus-specific polypeptides in infected cells. Virology. 121:1982;116-132
132. Volpini L.M., Calnek B.W., Sekellick M.J., Marcus P.I. Stages of Marek's-disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression. Vet. Microbiol. 47:1995;99-109
133. Volpini L.M., Calnek B.W., Sneath B., Sekellick M.J., Marcus P.I. Interferon modulation of Marek's disease virus genome expression in chicken cell lines. Avian Dis. 40:1996;78-87
134. Von Bulow V., Biggs P.M. Differentiation between strains of Marek's disease virus and turkey herpesvirus by immunofluorescence assays. Avian Pathol. 4:1974;133-146
135. Von Bulow V., Klasen A. Effects of avian viruses on cultured chicken bone-marrow-derived macrophages. Avian Pathol. 12:1983;179-198
136. Von Bulow V., Klasen A. Growth inhibition of Marek's disease T-lymphoblastoid cell lines by chicken bone-marrow-derived macrophages activated in vitro. Avian Pathol. 12:1983;161-178
137. Witter R., Sharma J., Solomon J., Champion L. An age-related resistance of chickens to Marek's disease: some preliminary observations. Avian Pathol. 2:1973;43-54
138. Witter R.L. Marek's disease research - History and perspectives. Poult. Sci. 50:1971;333-342
139. Witter R.L. Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency. Avian Dis. 27:1983;113-132
140. Witter R.L. Influence of serotype and virus strain on synergism between Marek's disease vaccine viruses. Avian Pathol. 21:1992;601-614
141. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:1997;149-163
142. Witter R.L. The changing landscape of Marek's disease. Avian Pathol. 27:1998;S46-S53
143. Witter, R.L., 2001. Protective efficacy of Marek's disease vaccines. In: Hirai, K. (Ed.), Current Topics in Microbiology and Immunology. Springer, Berlin, pp. 57-90.
144. Witter R.L., Nazerian K., Purchase H.G., Burgoyne G.H. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:1970;525-538
145. Witter R.L., Sharma J.M., Fadley A.M. Pathogenicity of variant Marek's disease virus isolates in vaccinated and unvaccinated chickens. Avian Dis. 24:1980;210-232
146. Witter R.L., Sharma J.M., Lee L.F., Opitz H.M., Henry C.W. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Dis. 28:1984;44-60
147. Xing Z., Schat K.A. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology. 100:2000;70-76
148. Xing Z., Schat K.A. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J. Virol. 74:2000;3605-3612